The invention relates to the isolation and preparation of an active fraction from plant Cuminum cyminum, its further purification and standardization as chemically defined entity (ies) with their intended use as drug bioavailability enhancer for the drugs belonging to therapeutic categories such as antimicrobial, antifungal, anti-viral, antitubercular, antileprosy, anti-inflammatory, antiarthritic, cardiovascular, antihistaminics, respiratory distress relieving drugs, immunosuppressants, anti-ulcerogenic, anti- cancer, CNS drugs, corticosteroids, nutraceuticals in compositions to be administered orally/parenterally, topically, inhalations (including nebulizers), rectally, vaginally in human beings and/or veterinary conditions.
Filing Date: 18-07-2003
Issue Date: 09-12-2007
Patent No: EP1526860 [Europe]
Application No: EP20030741062
Inventor(s): Qazi, Ghulam Nabi; Bedi, Kasturi Lal; Johri, Rakesh Kamal; Sharma, Subhash Chander; Tikoo, Manoj Kumar; Tikoo, Ashok Kumar; Abdullah Sheikh Tasaduq; Singh, Kuldeep; Pandita, Rashmi; Suri, Om Parkash; Gupta, Bisham Datt; Suri, Krishan Avtar; Satti, Naresh Kumar; Khajuria, Ravi Kant; Kapahi, Bal Krishan; Kalsotra, Ashok Kumar; Verma, Neelam; Anand Rajneesh 
Licensing Option: Laboratory willing to jointly develop technology with industrial partner.
Implementing institute: CSIR-Indian Institute of Integrative Medicine [CSIR-IIIM]
Funding agency: Council of Scientific and Industrial Research (CSIR)
IPC Classification: A61K36/23, A23L1/30, A61K9/00, A61K31/00, A61K31/35, A61K31/7048, A61K36/00, A61K36/185, A61K36/28, A61K36/47, A61K36/59, A61K36/80, A61K36/8965, A61K45/00, A61K45/06, A61K47/12, A61K47/26, A61K47/46, A61P3/02, A61P9/00, A61P11/00, A61P19/02, A61P25/00, A
